Navigation Links
QuatRx Pharmaceuticals Announces Positive Phase 3 Results for Study of Ophena(TM) (ospemifene) to Treat Postmenopausal Vaginal Syndrome
Date:1/3/2008

Novel non-estrogen oral therapy in development for menopausal symptoms

ANN ARBOR, Mich., Jan. 3 /PRNewswire/ -- QuatRx Pharmaceuticals Company today announced positive results from a pivotal Phase 3 study of Ophena(TM) (ospemifene) to treat postmenopausal women with vulvovaginal atrophy, a common condition associated with menopause. Top line data show that the multi-center, double-blind, placebo-controlled study successfully met all of its co-primary endpoints. The study was conducted in 80 U.S. centers and involved more than 800 women. Full results of the study are being submitted to an upcoming scientific meeting for release later in 2008.

Ophena(TM) is a novel selective estrogen receptor modulator (SERM) that is being studied as a treatment for women with postmenopausal vaginal syndrome (PVS), also known as vaginal atrophy. PVS is a common condition in postmenopausal women characterized by symptoms such as vaginal dryness, irritation and pain associated with sexual intercourse. The only currently FDA approved products for this condition all contain the hormone estrogen. However, many women and their physicians avoid using estrogen-containing products due to concerns about the risks of such therapy identified in the Women's Health Initiative (WHI) and other studies.

"These results are very exciting and we believe demonstrate that Ophena(TM) has the potential to bring clear clinical benefit to women affected by PVS, many of whom have had only estrogen therapy as a treatment option for their condition to date," said Robert L. Zerbe, M.D., chief executive officer and president of QuatRx. "We believe Ophena(TM) could provide the first non- estrogen prescription treatment alternative for this condition. QuatRx is well positioned to continue with our plans to advance this exciting product to commercialization, pending regulatory review and approval."

This pivotal Phase 3 study was designed to evaluate the efficacy of Ophena(TM) versus p
'/>"/>

SOURCE QuatRx Pharmaceuticals Company
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RIDGEWATER, N.J., Nov. 25 The FDA ...etravirine) tablets, a non-nucleoside reverse tran... NNRTI specifically indicated for use in treatment... failure with HIV-1 strains resistant to an NNRTI ...ional approval is based on 48-week data from two P...
(Date:11/25/2009)..., COLLEGE PARK, Md., Nov. 25 /PRNewswire-USNewswir...ping a shaving cream-like foam that stops severe b...romising Security Idea category of the Global Secu...day. ,, Selected from more than 100 entries fro...invention at the GSC Security Summit conference he...
(Date:11/25/2009)... BASKING RIDGE, N.J., Nov. 25 Rega...he development of antithrombotic aptamers with act...D, CEO and President, will be presenting at the Pi...the New York Palace Hotel in New York City. Dr. M...on Tuesday, December 1 and will include an overvie...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Ex NFL Players Hold Their Own Health Wise 59259 1Ex NFL Players Hold Their Own Health Wise 59259 2NHC Group CEO Paul Mirabelle Announces National Hearing Care 26apos 3Bs Proposal to Buy Bay Audiology Approved 59256 1How should mental neurological and substance use disorders be treated where resources are scarce 3F 59254 1How should mental neurological and substance use disorders be treated where resources are scarce 3F 59254 2
...ed in a physicians office practice, can be instrum...; UTIs, diabetes, several cancers, metabolic disor...imated global market for urinalysis tests is well ...strongly. For such a fundamental, extensive and ec...ufacturers of urinalysis analyzers comprise a surp...
...re.com ,According to a November, 2005 joint...rogramme on HIV/AIDS) and the World Health Organiz...ly reached an estimated high of 40.3 million peopl...DS. The latest data from the Centers for Disease ...United States are now living with HIV/AIDS and wit...
Other Medicine Technology:Urinalysis Analyzers: Large Capabilities in Every Size Device 2Urinalysis Analyzers: Large Capabilities in Every Size Device 3Rapid HIV Testing Increases Possibility of Treatment 2Rapid HIV Testing Increases Possibility of Treatment 3
(Date:11/27/2009)...27 /PRNewswire/ - Uploadable USB pedometers may be...lness. A combination of advanced accelerometer fun... long term concern over the accuracy of self-repor...d reward improved participation in a fitness progr...rst wellness suppliers to integrate this technolog...
(Date:11/27/2009)...PRNewswire-USNewswire/ -- Considered a highly risk...s ago, solid organ transplantation is now a life-s...nary men and women who gathered at the Winspear Op...her from medical centers around the world to celeb...plant Institute (BRTI), one of the pioneers of sol...
(Date:11/27/2009)...Nov. 27 Preventing dise...fortunately every year, new vaccines are being add...cines boost immunity for the same period of time? ...eeded to keep immunity strong? ,, In this mon...can Academy of Pediatrics, Michael Pichichero MD, ...
(Date:11/27/2009)...rael, Nov. 27 Shamir Opt...a leading provider of innovative products and tech...day that its board of directors had declared a div...0 million (approximately NIS 37.62 million based o...hange), or approximately US$ 0.609 (approximately ...
(Date:11/27/2009)...emission vehicles may reduce future disease burden...ealthDay News) -- Encouraging city dwellers to wal...ch greater public health benefits than increased u...e found. , The study compared the projected hea...sport scenarios for London, England, and Delhi, In...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2
...ult because of the blood-brain barrier, which prev...he bloodstream into the brain. In order for chemot...rrier. 'Thinking outside the box is a must f...ents for brain tumors are generally not effective....
...haps the most common respiratory disease after the...iversity of Southern California, teen-agers who sm...cted by asthma as compared to those who did not sm...or of preventive medicine at the Keck School of Me...
...r of chocolate, in celebration of some good news. ...s// its heart! When you melt to a bar of chocolate...inding. Researchers in the United States, J...n instruction to the subjects to avoid a number of...
...o play active sports like baseball, hockey, footba...to the chest although they// may be clad in protec...merican Heart Association meeting in Chicago revea...eartbeat called ventricular fibrillation. "If ...
...g and Alcohol Dependence- November issue, the risk...cents with arrest histories// than adolescents wit...ley Hasbro Children's Research Center and Brown Me...articipants included adolescents aged 15 to 21 who...
...earch worldwide the leaders of the world system ar...ir piggy banks to save// the poorest of the poor c...o a bleak era which seems to offer little in the ...o million people are diagnosed with diabetes in th...
Other Medicine News:Health News:Nanoparticles Used by Researchers to Attack Brain Tumours 2Health News:Teen-age Smokers at Higher Risk Of Developing Asthma 2Health News:Teen-age Smokers at Higher Risk Of Developing Asthma 3Health News:Athletic Gear in Youth Not Protective Against Near Fatal Blows to chest 2Health News:Adolescents With A History Of Arrest Are At Greater Risk For HIV Infection 2Health News:Poor diabetics: bitter times and worse times with no sweet respite 2
...uments were developed in surgeon's desire to have ...ument with the strength to maneuver into tight spa...rthrotek Hand Instruments are meticulously designe...d. This new generation of hand instrumentation is ...
...uments were developed in surgeon's desire to have ...ument with the strength to maneuver into tight spa...rthrotek Hand Instruments are meticulously designe...d. This new generation of hand instrumentation is ...
...uments were developed in surgeon's desire to have ...ument with the strength to maneuver into tight spa...rthrotek Hand Instruments are meticulously designe...d. This new generation of hand instrumentation is ...
...uments were developed in surgeon's desire to have ...ument with the strength to maneuver into tight spa...rthrotek Hand Instruments are meticulously designe...d. This new generation of hand instrumentation is ...
Medicine Products: